世界の血液代替物市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Blood Surrogates Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3921
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、109ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、血液代替物の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（HBOC、PFBOC）、用途別市場規模（病院、診療所、研究機関、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・血液代替物の市場動向
・企業の競争状況、市場シェア
・血液代替物の種類別市場規模と予測2016-2027（HBOC、PFBOC）
・血液代替物の用途別市場規模と予測2016-2027（病院、診療所、研究機関、その他）
・血液代替物の北米市場規模2016-2027（アメリカ、カナダ）
・血液代替物の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・血液代替物のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・血液代替物の中南米市場規模2016-2027（メキシコ、ブラジル）
・血液代替物の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Dextro-Sang Corporation、BioPure Corporation、Sangart、Northfield Laboratories、Baxter International、Dentritech、FluorO2 Therapeutics、Nuvox Pharma、Alpha Therapeutic Corporation、HemoBioTech）
・結論

Market Analysis and Insights: Global Blood Surrogates Market
The global Blood Surrogates market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Blood Surrogates market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Blood Surrogates market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Blood Surrogates market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Blood Surrogates market.

Global Blood Surrogates Scope and Market Size
Blood Surrogates market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Blood Surrogates market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
HBOC
PFBOC

Segment by Application
Hospital
Clinic
Research Institute
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Dextro-Sang Corporation
BioPure Corporation
Sangart
Northfield Laboratories
Baxter International
Dentritech
FluorO2 Therapeutics
Nuvox Pharma
Alpha Therapeutic Corporation
HemoBioTech

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blood Surrogates Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 HBOC
1.2.3 PFBOC
1.3 Market by Application
1.3.1 Global Blood Surrogates Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institute
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Blood Surrogates Market Perspective (2016-2027)
2.2 Blood Surrogates Growth Trends by Regions
2.2.1 Blood Surrogates Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Blood Surrogates Historic Market Share by Regions (2016-2021)
2.2.3 Blood Surrogates Forecasted Market Size by Regions (2022-2027)
2.3 Blood Surrogates Industry Dynamic
2.3.1 Blood Surrogates Market Trends
2.3.2 Blood Surrogates Market Drivers
2.3.3 Blood Surrogates Market Challenges
2.3.4 Blood Surrogates Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Blood Surrogates Players by Revenue
3.1.1 Global Top Blood Surrogates Players by Revenue (2016-2021)
3.1.2 Global Blood Surrogates Revenue Market Share by Players (2016-2021)
3.2 Global Blood Surrogates Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Blood Surrogates Revenue
3.4 Global Blood Surrogates Market Concentration Ratio
3.4.1 Global Blood Surrogates Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood Surrogates Revenue in 2020
3.5 Blood Surrogates Key Players Head office and Area Served
3.6 Key Players Blood Surrogates Product Solution and Service
3.7 Date of Enter into Blood Surrogates Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Blood Surrogates Breakdown Data by Type
4.1 Global Blood Surrogates Historic Market Size by Type (2016-2021)
4.2 Global Blood Surrogates Forecasted Market Size by Type (2022-2027)

5 Blood Surrogates Breakdown Data by Application
5.1 Global Blood Surrogates Historic Market Size by Application (2016-2021)
5.2 Global Blood Surrogates Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Blood Surrogates Market Size (2016-2027)
6.2 North America Blood Surrogates Market Size by Type
6.2.1 North America Blood Surrogates Market Size by Type (2016-2021)
6.2.2 North America Blood Surrogates Market Size by Type (2022-2027)
6.2.3 North America Blood Surrogates Market Size by Type (2016-2027)
6.3 North America Blood Surrogates Market Size by Application
6.3.1 North America Blood Surrogates Market Size by Application (2016-2021)
6.3.2 North America Blood Surrogates Market Size by Application (2022-2027)
6.3.3 North America Blood Surrogates Market Size by Application (2016-2027)
6.4 North America Blood Surrogates Market Size by Country
6.4.1 North America Blood Surrogates Market Size by Country (2016-2021)
6.4.2 North America Blood Surrogates Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Blood Surrogates Market Size (2016-2027)
7.2 Europe Blood Surrogates Market Size by Type
7.2.1 Europe Blood Surrogates Market Size by Type (2016-2021)
7.2.2 Europe Blood Surrogates Market Size by Type (2022-2027)
7.2.3 Europe Blood Surrogates Market Size by Type (2016-2027)
7.3 Europe Blood Surrogates Market Size by Application
7.3.1 Europe Blood Surrogates Market Size by Application (2016-2021)
7.3.2 Europe Blood Surrogates Market Size by Application (2022-2027)
7.3.3 Europe Blood Surrogates Market Size by Application (2016-2027)
7.4 Europe Blood Surrogates Market Size by Country
7.4.1 Europe Blood Surrogates Market Size by Country (2016-2021)
7.4.2 Europe Blood Surrogates Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Blood Surrogates Market Size (2016-2027)
8.2 Asia-Pacific Blood Surrogates Market Size by Type
8.2.1 Asia-Pacific Blood Surrogates Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Blood Surrogates Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Blood Surrogates Market Size by Type (2016-2027)
8.3 Asia-Pacific Blood Surrogates Market Size by Application
8.3.1 Asia-Pacific Blood Surrogates Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Blood Surrogates Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Blood Surrogates Market Size by Application (2016-2027)
8.4 Asia-Pacific Blood Surrogates Market Size by Region
8.4.1 Asia-Pacific Blood Surrogates Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Blood Surrogates Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Blood Surrogates Market Size (2016-2027)
9.2 Latin America Blood Surrogates Market Size by Type
9.2.1 Latin America Blood Surrogates Market Size by Type (2016-2021)
9.2.2 Latin America Blood Surrogates Market Size by Type (2022-2027)
9.2.3 Latin America Blood Surrogates Market Size by Type (2016-2027)
9.3 Latin America Blood Surrogates Market Size by Application
9.3.1 Latin America Blood Surrogates Market Size by Application (2016-2021)
9.3.2 Latin America Blood Surrogates Market Size by Application (2022-2027)
9.3.3 Latin America Blood Surrogates Market Size by Application (2016-2027)
9.4 Latin America Blood Surrogates Market Size by Country
9.4.1 Latin America Blood Surrogates Market Size by Country (2016-2021)
9.4.2 Latin America Blood Surrogates Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Blood Surrogates Market Size (2016-2027)
10.2 Middle East & Africa Blood Surrogates Market Size by Type
10.2.1 Middle East & Africa Blood Surrogates Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Blood Surrogates Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Blood Surrogates Market Size by Type (2016-2027)
10.3 Middle East & Africa Blood Surrogates Market Size by Application
10.3.1 Middle East & Africa Blood Surrogates Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Blood Surrogates Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Blood Surrogates Market Size by Application (2016-2027)
10.4 Middle East & Africa Blood Surrogates Market Size by Country
10.4.1 Middle East & Africa Blood Surrogates Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Blood Surrogates Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Dextro-Sang Corporation
11.1.1 Dextro-Sang Corporation Company Details
11.1.2 Dextro-Sang Corporation Business Overview
11.1.3 Dextro-Sang Corporation Blood Surrogates Introduction
11.1.4 Dextro-Sang Corporation Revenue in Blood Surrogates Business (2016-2021)
11.1.5 Dextro-Sang Corporation Recent Development
11.2 BioPure Corporation
11.2.1 BioPure Corporation Company Details
11.2.2 BioPure Corporation Business Overview
11.2.3 BioPure Corporation Blood Surrogates Introduction
11.2.4 BioPure Corporation Revenue in Blood Surrogates Business (2016-2021)
11.2.5 BioPure Corporation Recent Development
11.3 Sangart
11.3.1 Sangart Company Details
11.3.2 Sangart Business Overview
11.3.3 Sangart Blood Surrogates Introduction
11.3.4 Sangart Revenue in Blood Surrogates Business (2016-2021)
11.3.5 Sangart Recent Development
11.4 Northfield Laboratories
11.4.1 Northfield Laboratories Company Details
11.4.2 Northfield Laboratories Business Overview
11.4.3 Northfield Laboratories Blood Surrogates Introduction
11.4.4 Northfield Laboratories Revenue in Blood Surrogates Business (2016-2021)
11.4.5 Northfield Laboratories Recent Development
11.5 Baxter International
11.5.1 Baxter International Company Details
11.5.2 Baxter International Business Overview
11.5.3 Baxter International Blood Surrogates Introduction
11.5.4 Baxter International Revenue in Blood Surrogates Business (2016-2021)
11.5.5 Baxter International Recent Development
11.6 Dentritech
11.6.1 Dentritech Company Details
11.6.2 Dentritech Business Overview
11.6.3 Dentritech Blood Surrogates Introduction
11.6.4 Dentritech Revenue in Blood Surrogates Business (2016-2021)
11.6.5 Dentritech Recent Development
11.7 FluorO2 Therapeutics
11.7.1 FluorO2 Therapeutics Company Details
11.7.2 FluorO2 Therapeutics Business Overview
11.7.3 FluorO2 Therapeutics Blood Surrogates Introduction
11.7.4 FluorO2 Therapeutics Revenue in Blood Surrogates Business (2016-2021)
11.7.5 FluorO2 Therapeutics Recent Development
11.8 Nuvox Pharma
11.8.1 Nuvox Pharma Company Details
11.8.2 Nuvox Pharma Business Overview
11.8.3 Nuvox Pharma Blood Surrogates Introduction
11.8.4 Nuvox Pharma Revenue in Blood Surrogates Business (2016-2021)
11.8.5 Nuvox Pharma Recent Development
11.9 Alpha Therapeutic Corporation
11.9.1 Alpha Therapeutic Corporation Company Details
11.9.2 Alpha Therapeutic Corporation Business Overview
11.9.3 Alpha Therapeutic Corporation Blood Surrogates Introduction
11.9.4 Alpha Therapeutic Corporation Revenue in Blood Surrogates Business (2016-2021)
11.9.5 Alpha Therapeutic Corporation Recent Development
11.10 HemoBioTech
11.10.1 HemoBioTech Company Details
11.10.2 HemoBioTech Business Overview
11.10.3 HemoBioTech Blood Surrogates Introduction
11.10.4 HemoBioTech Revenue in Blood Surrogates Business (2016-2021)
11.10.5 HemoBioTech Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Blood Surrogates Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of HBOC
Table 3. Key Players of PFBOC
Table 4. Global Blood Surrogates Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Blood Surrogates Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Blood Surrogates Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Blood Surrogates Market Share by Regions (2016-2021)
Table 8. Global Blood Surrogates Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Blood Surrogates Market Share by Regions (2022-2027)
Table 10. Blood Surrogates Market Trends
Table 11. Blood Surrogates Market Drivers
Table 12. Blood Surrogates Market Challenges
Table 13. Blood Surrogates Market Restraints
Table 14. Global Blood Surrogates Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Blood Surrogates Market Share by Players (2016-2021)
Table 16. Global Top Blood Surrogates Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Blood Surrogates as of 2020)
Table 17. Ranking of Global Top Blood Surrogates Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Blood Surrogates Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Blood Surrogates Product Solution and Service
Table 21. Date of Enter into Blood Surrogates Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Blood Surrogates Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Blood Surrogates Revenue Market Share by Type (2016-2021)
Table 25. Global Blood Surrogates Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Blood Surrogates Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Blood Surrogates Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Blood Surrogates Revenue Market Share by Application (2016-2021)
Table 29. Global Blood Surrogates Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Blood Surrogates Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Blood Surrogates Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Blood Surrogates Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Blood Surrogates Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Blood Surrogates Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Blood Surrogates Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Blood Surrogates Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Blood Surrogates Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Blood Surrogates Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Blood Surrogates Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Blood Surrogates Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Blood Surrogates Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Blood Surrogates Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Blood Surrogates Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Blood Surrogates Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Blood Surrogates Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Blood Surrogates Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Blood Surrogates Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Blood Surrogates Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Blood Surrogates Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Blood Surrogates Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Blood Surrogates Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Blood Surrogates Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Blood Surrogates Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Blood Surrogates Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Blood Surrogates Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Blood Surrogates Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Blood Surrogates Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Blood Surrogates Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Blood Surrogates Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Blood Surrogates Market Size by Country (2022-2027) & (US$ Million)
Table 61. Dextro-Sang Corporation Company Details
Table 62. Dextro-Sang Corporation Business Overview
Table 63. Dextro-Sang Corporation Blood Surrogates Product
Table 64. Dextro-Sang Corporation Revenue in Blood Surrogates Business (2016-2021) & (US$ Million)
Table 65. Dextro-Sang Corporation Recent Development
Table 66. BioPure Corporation Company Details
Table 67. BioPure Corporation Business Overview
Table 68. BioPure Corporation Blood Surrogates Product
Table 69. BioPure Corporation Revenue in Blood Surrogates Business (2016-2021) & (US$ Million)
Table 70. BioPure Corporation Recent Development
Table 71. Sangart Company Details
Table 72. Sangart Business Overview
Table 73. Sangart Blood Surrogates Product
Table 74. Sangart Revenue in Blood Surrogates Business (2016-2021) & (US$ Million)
Table 75. Sangart Recent Development
Table 76. Northfield Laboratories Company Details
Table 77. Northfield Laboratories Business Overview
Table 78. Northfield Laboratories Blood Surrogates Product
Table 79. Northfield Laboratories Revenue in Blood Surrogates Business (2016-2021) & (US$ Million)
Table 80. Northfield Laboratories Recent Development
Table 81. Baxter International Company Details
Table 82. Baxter International Business Overview
Table 83. Baxter International Blood Surrogates Product
Table 84. Baxter International Revenue in Blood Surrogates Business (2016-2021) & (US$ Million)
Table 85. Baxter International Recent Development
Table 86. Dentritech Company Details
Table 87. Dentritech Business Overview
Table 88. Dentritech Blood Surrogates Product
Table 89. Dentritech Revenue in Blood Surrogates Business (2016-2021) & (US$ Million)
Table 90. Dentritech Recent Development
Table 91. FluorO2 Therapeutics Company Details
Table 92. FluorO2 Therapeutics Business Overview
Table 93. FluorO2 Therapeutics Blood Surrogates Product
Table 94. FluorO2 Therapeutics Revenue in Blood Surrogates Business (2016-2021) & (US$ Million)
Table 95. FluorO2 Therapeutics Recent Development
Table 96. Nuvox Pharma Company Details
Table 97. Nuvox Pharma Business Overview
Table 98. Nuvox Pharma Revenue in Blood Surrogates Business (2016-2021) & (US$ Million)
Table 99. Nuvox Pharma Recent Development
Table 100. Alpha Therapeutic Corporation Company Details
Table 101. Alpha Therapeutic Corporation Business Overview
Table 102. Alpha Therapeutic Corporation Blood Surrogates Product
Table 103. Alpha Therapeutic Corporation Revenue in Blood Surrogates Business (2016-2021) & (US$ Million)
Table 104. Alpha Therapeutic Corporation Recent Development
Table 105. HemoBioTech Company Details
Table 106. HemoBioTech Business Overview
Table 107. HemoBioTech Blood Surrogates Product
Table 108. HemoBioTech Revenue in Blood Surrogates Business (2016-2021) & (US$ Million)
Table 109. HemoBioTech Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Blood Surrogates Market Share by Type: 2020 VS 2027
Figure 2. HBOC Features
Figure 3. PFBOC Features
Figure 4. Global Blood Surrogates Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Research Institute Case Studies
Figure 8. Others Case Studies
Figure 9. Blood Surrogates Report Years Considered
Figure 10. Global Blood Surrogates Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Blood Surrogates Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Blood Surrogates Market Share by Regions: 2020 VS 2027
Figure 13. Global Blood Surrogates Market Share by Regions (2022-2027)
Figure 14. Global Blood Surrogates Market Share by Players in 2020
Figure 15. Global Top Blood Surrogates Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Blood Surrogates as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Blood Surrogates Revenue in 2020
Figure 17. Global Blood Surrogates Revenue Market Share by Type (2016-2021)
Figure 18. Global Blood Surrogates Revenue Market Share by Type (2022-2027)
Figure 19. North America Blood Surrogates Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Blood Surrogates Market Share by Type (2016-2027)
Figure 21. North America Blood Surrogates Market Share by Application (2016-2027)
Figure 22. North America Blood Surrogates Market Share by Country (2016-2027)
Figure 23. United States Blood Surrogates Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Blood Surrogates Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Blood Surrogates Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Blood Surrogates Market Share by Type (2016-2027)
Figure 27. Europe Blood Surrogates Market Share by Application (2016-2027)
Figure 28. Europe Blood Surrogates Market Share by Country (2016-2027)
Figure 29. Germany Blood Surrogates Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Blood Surrogates Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Blood Surrogates Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Blood Surrogates Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Blood Surrogates Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Blood Surrogates Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Blood Surrogates Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Blood Surrogates Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Blood Surrogates Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Blood Surrogates Market Share by Region (2016-2027)
Figure 39. China Blood Surrogates Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Blood Surrogates Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Blood Surrogates Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Blood Surrogates Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Blood Surrogates Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Blood Surrogates Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Blood Surrogates Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Blood Surrogates Market Share by Type (2016-2027)
Figure 47. Latin America Blood Surrogates Market Share by Application (2016-2027)
Figure 48. Latin America Blood Surrogates Market Share by Country (2016-2027)
Figure 49. Mexico Blood Surrogates Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Blood Surrogates Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Blood Surrogates Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Blood Surrogates Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Blood Surrogates Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Blood Surrogates Market Share by Country (2016-2027)
Figure 55. Turkey Blood Surrogates Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Blood Surrogates Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Blood Surrogates Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Dextro-Sang Corporation Revenue Growth Rate in Blood Surrogates Business (2016-2021)
Figure 59. BioPure Corporation Revenue Growth Rate in Blood Surrogates Business (2016-2021)
Figure 60. Sangart Revenue Growth Rate in Blood Surrogates Business (2016-2021)
Figure 61. Northfield Laboratories Revenue Growth Rate in Blood Surrogates Business (2016-2021)
Figure 62. Baxter International Revenue Growth Rate in Blood Surrogates Business (2016-2021)
Figure 63. Dentritech Revenue Growth Rate in Blood Surrogates Business (2016-2021)
Figure 64. FluorO2 Therapeutics Revenue Growth Rate in Blood Surrogates Business (2016-2021)
Figure 65. Nuvox Pharma Revenue Growth Rate in Blood Surrogates Business (2016-2021)
Figure 66. Alpha Therapeutic Corporation Revenue Growth Rate in Blood Surrogates Business (2016-2021)
Figure 67. HemoBioTech Revenue Growth Rate in Blood Surrogates Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

以下、関連資料のご紹介

世界の腫瘍血液検査市場規模・現状・予測（2021年-2027年）

Global Oncology Blood Testing Market Size, Status and Forecast 2021-2027
QFJ1-4605 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、腫瘍血液検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（肺がん、乳がん、結腸直腸がん、前立腺がん、胃がん、その）、用途別市場規模（病院、クリニック、外来手術センター）、主要地域別市場規模（北米、ア...

世界の代用血液市場規模・現状・予測（2021年-2027年）

Global Blood Substitute Market Size, Status and Forecast 2021-2027
QFJ1-3920 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、代用血液の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（HBOC、PFBOC）、用途別市場規模（病院、診療所、研究機関、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イ...

世界の血糖セルフモニタリング市場規模・現状・予測（2021年-2027年）

Global Self Blood Glucose Monitoring Market Size, Status and Forecast 2021-2027
QFJ1-4852 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、血糖セルフモニタリングの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（血糖値計、テストストリップ、ブラッドランセット、その他）、用途別市場規模（病院、クリニック、個人、その他）、主要地域別市場規模（北...

世界の全血球計算（CBC）市場規模・現状・予測（2021年-2027年）

Global Complete Blood Count(CBC) Market Size, Status and Forecast 2021-2027
QFJ1-5129 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、全血球計算（CBC）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（WBC数、RBC数、血小板数）、用途別市場規模（病院、参照研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の血液＆血液成分市場規模・現状・予測（2021年-2027年）

Global Blood and Blood Components Market Size, Status and Forecast 2021-2027
QFJ1-3915 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、血液＆血液成分の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（全血、血液成分）、用途別市場規模（貧血、外傷＆外科、がん治療、出血性疾患、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界の血中尿素窒素診断市場規模・現状・予測（2021年-2027年）

Global Blood Urea Nitrogen Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-3923 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、血中尿素窒素診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ELISA、比色法、分光法）、用途別市場規模（病院、研究所、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中...

世界の血液チューブシステム市場規模・現状・予測（2021年-2027年）

Global Blood Tubing Systems Market Size, Status and Forecast 2021-2027
QFJ1-3922 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、血液チューブシステムの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（血液チューブ、ドリップチャンバー、その他）、用途別市場規模（透析センター、病院＆クリニック）、主要地域別市場規模（北米、アメリカ、欧...

世界の血球分離市場規模・現状・予測（2021年-2027年）

Global Blood Cell Separation Market Size, Status and Forecast 2021-2027
QFJ1-3917 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、血球分離の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（人間細胞、動物細胞）、用途別市場規模（生体分子分離、癌研究、幹細胞研究、体外診断）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国...

世界の血圧モニタリング装置市場規模・現状・予測（2021年-2027年）

Global Blood Pressure Monitoring Devices Market Size, Status and Forecast 2021-2027
QFJ1-5103 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、血圧モニタリング装置の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アネロイド血圧計、デジタル血圧計、血圧計付属品、自由行動下血圧計）、用途別市場規模（病院、診療所、その他エンドユーザー）、主要地域別...

世界のIgEアレルギー血液検査市場規模・現状・予測（2021年-2027年）

Global IgE Allergy Blood Test Market Size, Status and Forecast 2021-2027
QFJ1-4346 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、IgEアレルギー血液検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ELISA試験、蛍光酵素免疫測定法（FEIA）試験、化学発光免疫測定法試験）、用途別市場規模（病院、診療所、診断研究所）、主要地...

世界の代用血液市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Blood Substitute Market The global Blood Substitute market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a b…
世界の血糖セルフモニタリング市場規模・現状・予測（2021年-2027年） Self Blood Glucose Monitoring is an approach whereby people withdiabetes measure their blood sugar (glycemia) themselves using a glycemic reader. Market Analysis and Insights: Global Self Blood Glucose Monitoring Market The global Self Blood Glucose Monitoring market size is projected to reach US$ 1…
世界の血液チューブシステム市場規模・現状・予測（2021年-2027年） Blood tubing systems are disposable accessories used in dialysis systems removing waste substances from the blood of patients with end-stage renal disease. Market Analysis and Insights: Global Blood Tubing Systems Market The global Blood Tubing Systems market size is projected to reach US$ XX millio…
世界の腫瘍血液検査市場規模・現状・予測（2021年-2027年） Oncology blood testing is a revolutionary diagnostic technique to detect cancer in early stages. For early detection of cancer, liquid biopsies have become a popular diagnostic tool. Market Analysis and Insights: Global Oncology Blood Testing Market The global Oncology Blood Testing market size is p…
世界の血液＆血液成分市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Blood and Blood Components Market The global Blood and Blood Components market size is projected to reach US$ 35100 million by 2027, from US$ 28990 million in 2020, at a CAGR of 2.3% during 2021-2027. With industry-standard accuracy in analysis and high data inte…